A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn’s disease
2025 · Journal of Crohn s and Colitis · 8 citations
https://doi.org/10.1093/ecco-jcc/jjaf070
B
Blake Kassmeyer
Mayo Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
140
Citations
7
h-index
4
i10-index
Blake Kassmeyer is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Inflammatory Bowel Disease & Eosinophilic Esophagitis & Microscopic Colitis. The author has an h-index of 7, co-authored 21 publications.
Papers by this author
worksRadiation dose reduction in pediatric computed tomography (CT) using deep convolutional neural network denoising
2024 · Clinical Radiology · 2 citations
https://doi.org/10.1016/j.crad.2024.09.011
Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal adenocarcinoma: a case-cohort study
2025 · Journal of Crohn s and Colitis · 0 citations
https://doi.org/10.1093/ecco-jcc/jjaf022
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat